Kathleen D. Scott's Net Worth
$43.2 Thousand
Who is Kathleen D. Scott?
Kathleen D. Scott does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Conatus Pharmaceuticals Inc., Dermata Therapeutics, Inc., ARS Pharmaceuticals, Inc., and NKGen Biotech, Inc..
SEC CIK
Kathleen D. Scott's CIK is 0001794284
Past Insider Trading and Trends
2022 was Kathleen D. Scott's most active year for acquiring shares with 5 total transactions. Kathleen D. Scott's most active month to acquire stocks was the month of December. 2022 saw Kathleen D. Scott paying a total of $0.00 for 859,475 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Conatus Pharmaceuticals Inc. (HSTO) Snapshot price: $0.2225
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermata Therapeutics, Inc. (DRMA) Snapshot price: $1.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +71.96% | 11.36K |
—
|
—
| 27.14K |
Oct 6
| |||
Form 4
| +170.96% | 9.96K |
—
|
—
| 15.79K |
Jul 7
| |||
Form 4
|
∞
| 5.83K |
—
|
—
| 5.83K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $11.5
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$8.75 | -$181,250.00 | 4.95K |
Scheduled
|
Oct 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 8.25K |
$6.24 | $51,506.40 | 8.25K |
Nov 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NKGen Biotech, Inc. (NKGN) Snapshot price: $0.7887
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||